Physician profile
John C Lim
NPI 1508899493
$2,525.15
in general payments reported to CMS, 2019-2025
26 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $226 · 2021: $598 · 2022: $407 · 2023: $242 · 2024: $340 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $427.13 | 2019-2024 | Tymlos |
| Abbvie INC. | $371.73 | 2019-2022 | |
| Novo Nordisk INC | $247.18 | 2019-2024 | Wegovy |
| Evofem Biosciences, INC. | $163.68 | 2020-2025 | Solosec, Phexx, Phexxi |
| Millicent US INC | $152.63 | 2021-2025 | Femring, Intrarosa, Femlyv |
| Roche Diagnostics Corporation | $119.41 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $114.68 | 2019 | |
| Therapeuticsmd, INC. | $106.76 | 2019-2021 | |
| Pfizer INC. | $99.99 | 2021-2023 | |
| Lilly USA, LLC | $93.56 | 2024 | Zepbound |
| Exact Sciences Corporation | $85.09 | 2024-2025 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $80.64 | 2021-2025 | |
| Myovant Sciences INC. | $68.57 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $57.03 | 2023-2024 | Myfembree |
| Heron Therapeutics, INC. | $48.97 | 2024 | Zynrelef |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $38.48 | 2022-2024 | Slynd |
| Ascend Therapeutics US, LLC | $36.85 | 2023-2024 | |
| Ethicon US, LLC | $34.98 | 2019-2021 | |
| Allergan, INC. | $34.24 | 2019 | |
| Medtronic, INC. | $29.76 | 2023 | Sonicision |
| Avion Pharmaceuticals | $28.38 | 2021-2023 | Balcoltra |
| Aspira Women'S Health INC | $26.28 | 2022 | |
| Sage Therapeutics, LLC | $19.78 | 2025 | Zurzuvae |
| Kowa Pharmaceuticals America, INC. | $14.05 | 2023 | Livalo, Seglentis |
| Mission Pharmacal Company | $13.85 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.